Minnesota MN
Eli Lilly releases more data for new obesity drug, moving toward fast-track approval
Eli Lilly is seeking FDA approval for tirzepatide for chronic weight management. The drug could be approved by the end of the year.Eli Lilly & co. In the summer of 2022, just as th…
